A. J. Keller

2.9k total citations
63 papers, 1.9k citations indexed

About

A. J. Keller is a scholar working on Epidemiology, Management of Technology and Innovation and Hepatology. According to data from OpenAlex, A. J. Keller has authored 63 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 20 papers in Management of Technology and Innovation and 16 papers in Hepatology. Recurrent topics in A. J. Keller's work include Blood donation and transfusion practices (20 papers), Hepatitis B Virus Studies (14 papers) and Hepatitis C virus research (12 papers). A. J. Keller is often cited by papers focused on Blood donation and transfusion practices (20 papers), Hepatitis B Virus Studies (14 papers) and Hepatitis C virus research (12 papers). A. J. Keller collaborates with scholars based in Australia, United Kingdom and United States. A. J. Keller's co-authors include Clive R. Seed, Philip Kiely, S. J. Urbaniak, T.J. Cobain, E. A. C. Follett, Tom Krusius, P.L. Yap, F. McOmish, Elina Kolho and R. Naukkarinen and has published in prestigious journals such as Blood, Journal of Clinical Microbiology and British Journal of Haematology.

In The Last Decade

A. J. Keller

62 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. J. Keller Australia 23 879 751 406 353 333 63 1.9k
J. A. J. Barbara United Kingdom 27 942 1.1× 529 0.7× 483 1.2× 321 0.9× 434 1.3× 125 2.9k
Edward P. Notari United States 26 789 0.9× 484 0.6× 1.2k 2.9× 381 1.1× 425 1.3× 55 2.4k
Silvano Wendel Brazil 20 558 0.6× 106 0.1× 197 0.5× 158 0.4× 580 1.7× 71 1.6k
Giuliano Grazzini Italy 22 231 0.3× 102 0.1× 267 0.7× 545 1.5× 382 1.1× 72 1.7k
Maria Elena Tosti Italy 33 1.7k 2.0× 1.7k 2.2× 42 0.1× 652 1.8× 181 0.5× 125 2.9k
Mulugeta Melku Ethiopia 24 304 0.3× 48 0.1× 152 0.4× 346 1.0× 436 1.3× 74 1.5k
M J Alter United States 25 4.6k 5.2× 5.1k 6.7× 88 0.2× 796 2.3× 126 0.4× 55 6.1k
Daniel J. Tisch United States 18 179 0.2× 43 0.1× 89 0.2× 276 0.8× 133 0.4× 39 1.7k
Carlo Bonfanti Italy 24 430 0.5× 105 0.1× 13 0.0× 258 0.7× 502 1.5× 90 1.8k
Anne F. Eder United States 29 194 0.2× 49 0.1× 1.3k 3.1× 168 0.5× 741 2.2× 77 2.7k

Countries citing papers authored by A. J. Keller

Since Specialization
Citations

This map shows the geographic impact of A. J. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. J. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. J. Keller more than expected).

Fields of papers citing papers by A. J. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. J. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. J. Keller. The network helps show where A. J. Keller may publish in the future.

Co-authorship network of co-authors of A. J. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of A. J. Keller. A scholar is included among the top collaborators of A. J. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. J. Keller. A. J. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shrestha, Ashish C., Robert L. Flower, Clive R. Seed, et al.. (2017). Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply.. PubMed. 15(3). 191–198. 4 indexed citations
2.
Seed, Clive R., et al.. (2017). Reconsideration of blood donation testing strategy for human T‐cell lymphotropic virus in Australia. Vox Sanguinis. 112(8). 723–732. 18 indexed citations
3.
Shrestha, Ashish C., Helen M. Faddy, Robert L. Flower, Clive R. Seed, & A. J. Keller. (2014). Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history?. Pathology. 47(2). 97–100. 9 indexed citations
5.
Pasricha, Sant‐Rayn, Zoe McQuilten, M. Westerman, et al.. (2011). Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica. 96(8). 1099–1105. 79 indexed citations
6.
Pasricha, Sant‐Rayn, Zoe McQuilten, A. J. Keller, & Erica M. Wood. (2011). Hemoglobin and iron indices in nonanemic premenopausal blood donors predict future deferral from whole blood donation. Transfusion. 51(12). 2709–2713. 22 indexed citations
8.
Seed, Clive R., Philip Kiely, Catherine A. Hyland, & A. J. Keller. (2009). The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia. Transfusion. 49(7). 1482–1487. 40 indexed citations
9.
Dunstan, Robert A., Clive R. Seed, & A. J. Keller. (2008). Emerging viral threats to the Australian blood supply. Australian and New Zealand Journal of Public Health. 32(4). 354–360. 26 indexed citations
10.
Musto, Jennie, Clive R. Seed, Matthew Law, A. J. Keller, & John Kaldor. (2008). Estimating the risk of blood donation associated with HIV risk behaviours. Transfusion Medicine. 18(1). 49–54. 9 indexed citations
12.
13.
Seed, Clive R., Philip Kiely, & A. J. Keller. (2005). Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Internal Medicine Journal. 35(10). 592–598. 72 indexed citations
15.
Correll, Patricia, Matthew Law, Clive R. Seed, et al.. (2001). Variant Creutzfeldt‐Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies. Vox Sanguinis. 81(1). 6–11. 18 indexed citations
16.
Holman, C. D’Arcy J., et al.. (1989). Population‐based epidemiology of human immunodeficiency virus infection in Western Australia. The Medical Journal of Australia. 150(7). 362–370. 5 indexed citations
17.
Wenig, Barry L. & A. J. Keller. (1989). Microvascular Free Flap Reconstruction for Head and Neck Defects. Archives of Otolaryngology - Head and Neck Surgery. 115(9). 1118–1120. 13 indexed citations
18.
Maskill, William J., et al.. (1986). Evaluation of a new assay for antibodies to LAV/HTLV III. Journal of Virological Methods. 13(4). 273–278. 5 indexed citations
19.
Swainson, C. P., et al.. (1978). Treatment of Goodpasture's disease by plasma exchange and immunosuppression.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 32(2). 233–42. 19 indexed citations
20.
Parker, A. C., et al.. (1977). Leukapheresis for papilloedema in chronic granulocytic leukaemia.. BMJ. 2(6088). 676–677. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026